This biotech firm wants to resurrect the dead — for science
May03
Philadelphia-based biotech company Bioquark, Inc. is seeking to awaken 20 dead people. Bioquark has been granted ethical approval from an Institutional Review Board at the National Institutes of Health in both the United States and India to complete a clinical trial at Anupam Hospital in India. Over a six week period, the company, through its ReAnima Project, will attempt to revive clinically dead patients — those only kept alive through use of life support — by using stem cells, nerve stimulation and other treatments. Dr. Ira Pastor, CEO of Bioquark said: This represents the first trial of its kind and another step towards…
This story continues at The Next Web